Pure Biologics SA
WSE:PUR
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Pure Biologics SA
Free Cash Flow
Pure Biologics SA
Free Cash Flow Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Free Cash Flow | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
P
|
Pure Biologics SA
WSE:PUR
|
Free Cash Flow
-zł6.6m
|
CAGR 3-Years
26%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
M
|
Mabion SA
WSE:MAB
|
Free Cash Flow
-zł41.5m
|
CAGR 3-Years
15%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
2%
|
|
|
R
|
Read Gene SA
WSE:RDG
|
Free Cash Flow
-zł127.5k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
21%
|
|
|
B
|
Bioton SA
WSE:BIO
|
Free Cash Flow
zł9.6m
|
CAGR 3-Years
-29%
|
CAGR 5-Years
-24%
|
CAGR 10-Years
N/A
|
|
|
U
|
Urteste SA
WSE:URT
|
Free Cash Flow
-zł14.4m
|
CAGR 3-Years
-66%
|
CAGR 5-Years
-101%
|
CAGR 10-Years
N/A
|
|
|
S
|
Synthaverse SA
WSE:SVE
|
Free Cash Flow
-zł23.2m
|
CAGR 3-Years
8%
|
CAGR 5-Years
-44%
|
CAGR 10-Years
2%
|
|
Pure Biologics SA
Glance View
Pure Biologics SA is a biopharmaceutical company, which engages in the research and development of innovative biological medicines and medical devices for use therapeutic and diagnostic tests. The company is headquartered in Wroclaw, Woj. Dolnoslaskie and currently employs 101 full-time employees. The company went IPO on 2018-12-11. The firm was founded in August 2010 and is located in Wroclaw, Poland.
See Also
What is Pure Biologics SA's Free Cash Flow?
Free Cash Flow
-6.6m
PLN
Based on the financial report for Jun 30, 2025, Pure Biologics SA's Free Cash Flow amounts to -6.6m PLN.
What is Pure Biologics SA's Free Cash Flow growth rate?
Free Cash Flow CAGR 3Y
26%
Over the last year, the Free Cash Flow growth was 58%. The average annual Free Cash Flow growth rates for Pure Biologics SA have been 26% over the past three years .
